A

Alberta Health Services | Alberta Children's Hospital, Department of Neurosciences

Research site
(Unclaimed)
Location
28 Oki Drive North East, Calgary, Alberta, Canada
Site insights

Top conditions

Hypertension (2 trials)

Emergencies (2 trials)

Varicose Ulcer (1 trial)

Colorectal Cancer (1 trial)

Bone Fractures (1 trial)

Top treatments

Macitentan
Dexamethasone
Lebrikizumab
TAK-659
CyBorD
Acetylsalicyclic acid
S42909
Oseltamivir
Tadalafil
MHAA4549A

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 19
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

The purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared...

Active, not recruiting
Amyloidosis
Drug: Cyclophosphamide
Drug: Daratumumab

Combination therapy in pulmonary arterial hypertension (PAH) has been the subject of active investigation for more than a decade, with the benefit of...

Active, not recruiting
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Drug: Tadalafil 40 mg
Drug: Placebo FDC

Trial sponsors

Actelion Pharmaceuticals logo

Actelion Pharmaceuticals (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems